Zacks: Analysts predict Masimo Co. (MASI) will post $ 0.72 in earnings per share

Business



[ad_1]

Masimo logo "title =" Masimo logo "clbad =" companylogo "/> Stock research badysts expect Masimo Co. (NASDAQ: MASI) to post earnings per share of 0, $ 72 for the current fiscal quarter Masimo reported earnings of $ 0.83 per share in the same quarter last year, suggesting a year - on - year negative growth rate. The company is expected to announce its next quarterly earnings report on Wednesday, August 1. </p> <p> According to Zacks, badysts expect Masimo to post an annual profit of $ 2.89 per share for the company. Current year For the upcoming year, badysts expect the firm to report earnings of $ 2.98 per share, with earnings per share estimates of $ 2.92 to $ 3.03. Analysts who cover Masimo </p> <p> Masimo (NASDAQ: MASI) has announced its quarterly results for the last time on Wednesday, May 2nd. The medical equipment provider reported earnings per share of $ 0.75 for the quarter, surpbading the consensus estimate of $ 0.69 per $ 0.06. Masimo recorded a net margin of 15.99% and a return on equity of 23.14%. The company achieved a turnover of $ 212.90 million for the quarter, against $ 205.65 million for badysts. In the same quarter of the previous year, the company posted earnings per share of $ 0.57. Masimo 's quarterly business figure rose 8.3% year on year. </p> <p> A number of research badysts weighed on the stock. BidaskClub cut Masimo's shares from a "strong buy" rating to a "buy" note in a research report on Saturday, June 30. BTIG Research reiterated a "buy" note and set a target price of $ 100.00 on Masimo shares in a research report on Thursday, May 3rd. Zacks Investment Research cut Masimo's shares from a "buy" note to a "hold" note in a research report on Tuesday, May 1st. Piper Jaffray raised their price target on Masimo shares to $ 94.00 and awarded the company a "neutral" rating in a research report on Wednesday, May 2. Finally, ValuEngine updated the shares of Masimo, which went from "hold" to "buy" in a research report on Monday, July 2nd. An badyst rated the stock with a reserve note and seven gave a buy-to-action rating. Masimo currently has a "Buy" rating by consensus and a consensus price target of $ 102.33 </p> <p> By the way, EVP Yongsam Lee has sold 4,100 shares of the company during a transaction on Tuesday, April 24. The shares were sold at an average price of $ 90.13, for a total transaction of $ 369,533.00. Following the sale, the Executive Vice-President now directly owns 72,200 shares of the Company, valued at $ 6,507,386. The sale has been disclosed in a legal deposit with the Securities & Exchange Commission, which can be found on the SEC's website. In addition, insider Jon Coleman sold 24,000 shares of the company during a transaction on Monday, April 23. The shares were sold at an average price of $ 90.00, for a total transaction of $ 2,160,000.00. As a result of the sale, the insider now directly owns 21,201 shares of the company, valued at $ 1,908,090. The disclosure for this sale can be found here. Insiders sold 107,900 shares valued at $ 10,104,057 during the last quarter. Insiders of the company own 12.60% of the shares of the company. </p> <p> Several institutional investors and hedge funds have recently changed their holdings in MASI. OppenheimerFunds Inc. increased its stake in Masimo by 36.6% in the fourth quarter. OppenheimerFunds Inc. now holds 4,505 shares of the medical equipment maker valued at $ 382,000 after purchasing 1,206 additional shares during the period. Alliancebernstein LP increased its stake in Masimo by 1.9% in the fourth quarter. Alliancebernstein LP now owns 106,691 shares of the medical equipment provider valued at $ 9,047,000 after purchasing 2,000 additional shares during the period. Amundi Pioneer Asset Management Inc. purchased a new stake in Masimo shares during the fourth quarter valued at $ 372,000. Deutsche Bank AG increased its stake in Masimo by 17.4% in the fourth quarter. Deutsche Bank AG now holds 227,863 shares of the medical equipment provider valued at $ 19,321,000 after purchasing 33,843 additional shares during the period. Finally, Paloma Partners Management Co acquired a new stake in Masimo shares during the fourth quarter, valued at $ 294,000. 83.12% of the shares are held by hedge funds and other institutional investors. </p> <p> Masimo fell $ 0.32, reaching $ 99.49, during the trading day Friday, reports MarketBeat. 264,524 shares were exchanged, compared with an average volume of 784,937 shares. Masimo has a minimum of $ 80.69 in one year and $ 102.32 in one year. The stock has a market capitalization of $ 5.11 billion, a price / earnings ratio of 40.61, a price / earnings ratio of 2.35 and a beta of 0.94. </p> <p> <strong> Masimo Company Profile </strong> </p> <p> Masimo Corporation, a medical technology company, develops, manufactures, and markets non-invasive surveillance technologies worldwide. The company offers Masimo signal extraction pulse rate oximetry (SET) with pulse-by-motion and low-perfusion pulse oximetry monitoring to address primary limitations conventional pulse oximetry. <!--ViewCount:ArticleHistoryID=21374506&PostDate=2018-7-14&type=c&id=431375--> <!--Keyword: Masimo,NASDAQ:MASI,MASI,Medical,57479510,Ratings,Consensus--> <!--Ratings:4,5,NASDAQ:MASI--> </p> <p> Copy of Zacks Research Report on Masimo (MASI) </p> <p> For more information on Zacks Investment Research's research opportunities, visit Zacks.com </p> <p style= History and Earnings Estimates for Masimo (NASDAQ: MASI)

Receive news and ratings for Masimo Daily – Enter your email address below to receive a concise daily summary of the latest news and badyst ratings for Masimo and related companies with MarketBeat.com's FREE Daily E-newsletter.

[ad_2]
Source link

Tags

Powered by https://naaju.com/ireland | Designed by Naaju
© Copyright 2024, All Rights Reserved